Fungal Infections Market By Drugs Class And Drugs Indication - Global Industry Analysis And Forecast To 2023

Published On : May 2018 Pages : 190 Category: Healthcare IT Report Code : HC05796

Industry Outlook and Trend Analysis

The Fungal Infections Market has encountered significant growth in the recent years and is anticipated to grow tremendously over the forecast period.  Fungal infection is found to affect both systemic and superficial  parts of the body, in the skin, mouth, eye, and vagina, leading to illnesses, for example, fungal meningitis, athlete's foot, and ringworm, which are dealt with the help of antifungal products. The development is because of the rising frequency of fungal infections including as pergillosis and candidiasis. These diseases may cause death in patients with a weak immune system, for example, in people affected with AIDS and leukemia, and are consequently named as opportunistic infections.  The expanding prevalence of hospital-acquired infections and infectious diseases is anticipated to fuel the demand for therapeutics over the estimate time frame.

Indication Outlook and Trend Analysis

Dermatophytosis holds the dominant share because of rising frequency of skin infections in children. Rising pervasiveness of opportunistic fungal infections is foreseen to boost the demand over the figure time frame. Nonetheless, the most commonly occurring systemic fungal infection is systemic candidiasis which is anticipated to grow at a considerable CAGR over the gauge time frame.

Drug Class Outlook and Trend Analysis

Azoles are the type of antifungal drugs with broad-spectrum activity. This drug class ruled the portion in 2015 with driving therapeutic agents, for example, Vfend, Noxafil, and Diflucan. These agents exert fungistatic action by restraining fungal compounds. Azoles are used in the treatment of blastomycosis, candidemia, ocular fungal infections, and systemic candidiasis.

Regional Outlook and Trend Analysis

North America, owing to high patient awareness levels and R&D power relating to new medication improvement, drove the market in 2015 with an offer of 47.0%. Nonetheless, its share is anticipated to decrease by 2025 inferable from the development of different locales, for example, Asia Pacific and Latin America, growing at a speedier development rate. Asia Pacific is foreseen to witness the most elevated CAGR amid the gauge time frame. The existence of enormous target populace, developing establishment of healthcare facilities, and high neglected clinical needs identified with fungal infections are foreseen to give a potential development stage to this area for pharmaceutical players.

Competitive Insights

The leading players in the market are Enzon Pharmaceuticals, Abbott Laboratories, Merck & Co, SmithKline Beecham, Astellas Pharma, Pfizer, Sigma-Aldrich, Novartis and Bayer. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Fungal Infections Market is segmented as follows-

By Indication:

  • Aspergillosis
  • Candidiasis
  • Dermatophytosis
  • Othes

By Drug Class:

  • Echinocandins
  • Allylamines
  • Azoles
  • Polyenes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Fungal Infections Market, By Drugs Class, Estimates and Forecast, 2014-2023 ($Million)

·         Azoles

·         Echinocandins

·         Polyenes

·         Allylamines

·         Other Drugs Class

·         Fungal Infections Market, By Drugs Indication, Estimates and Forecast, 2014-2023 ($Million)

·         Dermatophytosis

·         Aspergillosis

·         Candidiasis

·         Other Drug Indications

·         Fungal Infections Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Fungal Infections Market, By Country

o    U.S. Fungal Infections Market

o    Canada Fungal Infections Market

o    Mexico Fungal Infections Market

·         Europe

§  Europe Fungal Infections Market, By Country

o    Germany Fungal Infections Market

o    UK Fungal Infections Market

o    France Fungal Infections Market

o    Russia Fungal Infections Market

o    Italy Fungal Infections Market

o    Rest of Europe Fungal Infections Market

·         Asia-Pacific

§  Asia-Pacific Fungal Infections Market, By Country

o    China Fungal Infections Market

o    Japan Fungal Infections Market

o    South Korea Fungal Infections Market

o    India Fungal Infections Market

o    Southeast Asia Fungal Infections Market

o    Rest of Asia-Pacific Fungal Infections Market

·         South America

§  South America Fungal Infections Market

o    Brazil Fungal Infections Market

o    Argentina Fungal Infections Market

o    Columbia Fungal Infections Market

o    South Africa Fungal Infections Market

o    Rest of South America Fungal Infections Market

·         Middle East and Africa

§  Middle East and Africa Fungal Infections Market

o    Saudi Arabia Fungal Infections Market

o    UAE Fungal Infections Market

o    Egypt Fungal Infections Market

o    Nigeria Fungal Infections Market

o    South Africa Fungal Infections Market

o    Rest of MEA Fungal Infections Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Fungal Infections Market, By Drug Class

5.1.       Introduction

5.2.       Global Fungal Infections Sales, Revenue and Market Share by Drug Class (2014-2018)

5.2.1.  Global Fungal Infections Sales and Sales Share by Drug Class (2014-2018)

5.2.2.  Global Fungal Infections Revenue and Revenue Share by Drug Class (2014-2018)

5.3.       Azoles

5.3.1.  Global Azoles Sales and Growth Rate (2014-2018)

5.4.       Echinocandins

5.4.1.  Global Echinocandins Sales and Growth Rate (2014-2018)

5.5.       Polyenes

5.5.1.  Global Polyenes Sales and Growth Rate (2014-2018)

5.6.       Allylamines

5.6.1.  Global Allylamines Sales and Growth Rate (2014-2018)

5.7.       Other Drug Classes

5.7.1.  Global Other Drug Classes Sales and Growth Rate (2014-2018)

6.       Fungal Infections Market, By Drugs Indication

6.1.       Introduction

6.2.       Global Fungal Infections Sales, Revenue and Market Share by Drugs Indication (2014-2018)

6.2.1.  Global Fungal Infections Sales and Sales Share by Drugs Indication (2014-2018)

6.2.2.  Global Fungal Infections Revenue and Revenue Share by Drugs Indication (2014-2018)

6.3.       Dermatophytosis

6.3.1.  Global Dermatophytosis Sales and Growth Rate (2014-2018)

6.4.       Aspergillosis

6.4.1.  Global Aspergillosis Sales and Growth Rate (2014-2018)

6.5.       Candidiasis

6.5.1.  Global Candidiasis Sales and Growth Rate (2014-2018)

6.6.       Other Drug Indications

6.6.1.  Global Other Drug Indications Sales and Growth Rate (2014-2018)

7.       Fungal Infections Market, By Region

7.1.       Introduction

7.2.       Global Fungal Infections Sales, Revenue and Market Share by Regions

7.2.1.  Global Fungal Infections Sales by Regions (2014-2018)

7.2.2.  Global Fungal Infections Revenue by Regions (2014-2018)

7.3.       North America Fungal Infections by Countries

7.3.1.  North America Fungal Infections Sales and Growth Rate (2014-2018)

7.3.2.  North America Fungal Infections Revenue and Growth Rate (2014-2018)

7.3.3.  North America Fungal Infections Sales by Countries (2014-2018)

7.3.4.  North America Fungal Infections Revenue (Million USD) by Countries (2014-2018)

7.3.5.  U.S.

7.3.5.1.    United States Fungal Infections Sales and Growth Rate (2014-2018)

7.3.5.2.    United States Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.6.  Canada

7.3.6.1.    Canada Fungal Infections Sales and Growth Rate (2014-2018)

7.3.6.2.    Canada Fungal Infections Sales (Millions USD) and Growth Rate (2014-2018)

7.3.7.  Mexico

7.3.7.1.    Mexico Fungal Infections Sales and Growth Rate (2014-2018)

7.3.7.2.    Mexico Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.       Europe Fungal Infections by Countries

7.4.1.  Europe Fungal Infections Sales and Growth Rate (2014-2018)

7.4.2.  Europe Fungal Infections Revenue and Growth Rate (2014-2018)

7.4.3.  Europe Fungal Infections Sales by Countries (2014-2018)

7.4.4.  Europe Fungal Infections Revenue (Million USD) by Countries (2014-2018)

7.4.5.  Germany

7.4.5.1.    Germany Fungal Infections Sales and Growth Rate (2014-2018)

7.4.5.2.    Germany Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  UK

7.4.6.1.    UK Fungal Infections Sales and Growth Rate (2014-2018)

7.4.6.2.    UK Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  France

7.4.7.1.    France Fungal Infections Sales and Growth Rate (2014-2018)

7.4.7.2.    France Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Russia

7.4.8.1.    Russia Fungal Infections Sales and Growth Rate (2014-2018)

7.4.8.2.    Russia Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.9.  Italy

7.4.9.1.    Italy Fungal Infections Sales and Growth Rate (2014-2018)

7.4.9.2.    Italy Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Fungal Infections Sales and Growth Rate (2014-2018)

7.4.10.2. Rest of Europe Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Fungal Infections Sales and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Fungal Infections Revenue and Growth Rate (2014-2018)

7.5.3.  Asia-Pacific Fungal Infections Sales by Countries (2014-2018)

7.5.4.  Asia-Pacific Fungal Infections Revenue (Million USD) by Countries (2014-2018)

7.5.5.  China

7.5.5.1.    China Fungal Infections Sales and Growth Rate (2014-2018)

7.5.5.2.    China Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  Japan

7.5.6.1.    Japan Fungal Infections Sales and Growth Rate (2014-2018)

7.5.6.2.    Japan Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Fungal Infections Sales and Growth Rate (2014-2018)

7.5.7.2.    Korea Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  India

7.5.8.1.    India Fungal Infections Sales and Growth Rate (2014-2018)

7.5.8.2.    India Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Fungal Infections Sales and Growth Rate (2014-2018)

7.5.9.2.    Southeast Asia Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Fungal Infections Sales and Growth Rate (2014-2018)

7.5.10.2. Rest of Asia-Pacific Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.       South America

7.6.1.  South America Fungal Infections Sales and Growth Rate (2014-2018)

7.6.2.  South America Fungal Infections Revenue and Growth Rate (2014-2018)

7.6.3.  South America Fungal Infections Sales by Countries (2014-2018)

7.6.4.  South America Fungal Infections Revenue (Million USD) by Countries (2014-2018)

7.6.5.  Brazil

7.6.5.1.    Brazil Fungal Infections Sales and Growth Rate (2014-2018)

7.6.5.2.    Brazil Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Argentina

7.6.6.1.    Argentina Fungal Infections Sales and Growth Rate (2014-2018)

7.6.6.2.    Argentina Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.7.  Columbia

7.6.7.1.    Columbia Fungal Infections Sales and Growth Rate (2014-2018)

7.6.7.2.    Columbia Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Fungal Infections Sales and Growth Rate (2014-2018)

7.6.8.2.    Rest of South America Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Fungal Infections Sales and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Fungal Infections Revenue and Growth Rate (2014-2018)

7.7.3.  Middle East and Africa Fungal Infections Sales by Countries (2014-2018)

7.7.4.  Middle East and Africa Fungal Infections Revenue (Million USD) by Countries (2014-2018)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Fungal Infections Sales and Growth Rate (2014-2018)

7.7.5.2.    Saudi Arabia Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Fungal Infections Sales and Growth Rate (2014-2018)

7.7.6.2.    United Arab Emirates Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  Egypt

7.7.7.1.    Egypt Fungal Infections Sales and Growth Rate (2014-2018)

7.7.7.2.    Egypt Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Fungal Infections Sales and Growth Rate (2014-2018)

7.7.8.2.    Nigeria Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  South Africa

7.7.9.1.    South Africa Fungal Infections Sales and Growth Rate (2014-2018)

7.7.9.2.    South Africa Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Fungal Infections Sales and Growth Rate (2014-2018)

7.7.10.2. Rest of Middle East and Africa Fungal Infections Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.       Novartis

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Pfizer Inc.

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Bayer Healthcare

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Sanofi-Aventis

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Merck & Co. Inc.

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       GlaxoSmithKline

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Abbott Laboratories

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       Glenmark Pharmaceuticals Ltd

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       Enzon Pharmaceuticals

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

8.10.    ID Sigma-Aldrich Corporation

8.10.1.      Business Overview

8.10.2.      Product Portfolio

8.10.3.      Strategic Developments

8.10.4.      Sales, Revenue and Market Share

9.       Global Fungal Infections Market Competition, by Manufacturer

9.1.       Global Fungal Infections Sales and Market Share by Manufacturer (2016-2017)

9.2.       Global Fungal Infections Revenue and Market Share by Manufacturer (2016-2017)

9.3.       Global Fungal Infections Price by Manufacturer (2016-2017)

9.4.       Top 5 Fungal Infections Manufacturer Market Share

9.5.       Market Competition Trend

10.   Fungal Infections Market Forecast (2018-2023)

10.1.    Global Fungal Infections Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

10.2.    Fungal Infections Market Forecast by Regions (2018-2023)

10.2.1.      North America Fungal Infections Market Forecast (2018-2023)

10.2.1.1. United States Fungal Infections Market Forecast (2018-2023)

10.2.1.2. Canada Fungal Infections Market Forecast (2018-2023)

10.2.1.3. Mexico Fungal Infections Market Forecast (2018-2023)

10.2.2.      Europe Fungal Infections Market Forecast (2018-2023)

10.2.2.1. Germany Fungal Infections Market Forecast (2018-2023)

10.2.2.2. United Kingdom Fungal Infections Market Forecast (2018-2023)

10.2.2.3. France Fungal Infections Market Forecast (2018-2023)

10.2.2.4. Russia Fungal Infections Market Forecast (2018-2023)

10.2.2.5. Italy Fungal Infections Market Forecast (2018-2023)

10.2.2.6. Rest of the Europe Fungal Infections Market Forecast (2018-2023)

10.2.3.      Asia-Pacific Fungal Infections Market Forecast (2018-2023)

10.2.3.1. China Fungal Infections Market Forecast (2018-2023)

10.2.3.2. Japan Fungal Infections Market Forecast (2018-2023)

10.2.3.3. Korea Fungal Infections Market Forecast (2018-2023)

10.2.3.4. India Fungal Infections Market Forecast (2018-2023)

10.2.3.5. Southeast Asia Fungal Infections Market Forecast (2018-2023)

10.2.3.6. Rest of Asia-Pacific Fungal Infections Market Forecast (2018-2023)

10.2.4.      South America Fungal Infections Market Forecast (2018-2023)

10.2.4.1. Brazil Fungal Infections Market Forecast (2018-2023)

10.2.4.2. Argentina Fungal Infections Market Forecast (2018-2023)

10.2.4.3. Columbia Fungal Infections Market Forecast (2018-2023)

10.2.4.4. Rest of South America Fungal Infections Market Forecast (2018-2023)

10.2.5.      Middle East and Africa Fungal Infections Market Forecast (2018-2023)

10.2.5.1. Saudi Arabia Fungal Infections Market Forecast (2018-2023)

10.2.5.2. UAE Fungal Infections Market Forecast (2018-2023)

10.2.5.3. Egypt Fungal Infections Market Forecast (2018-2023)

10.2.5.4. Nigeria Fungal Infections Market Forecast (2018-2023)

10.2.5.5. South Africa Fungal Infections Market Forecast (2018-2023)

10.2.5.6. Rest of MEA Fungal Infections Market Forecast (2018-2023)

10.3.    Fungal Infections Market Forecast by Drug Class (2018-2023)

10.3.1.      Global Fungal Infections Sales Forecast by Drug Class (2018-2023)

10.3.2.      Global Fungal Infections Sales Market Share Forecast by Drug Class (2018-2023)

10.4.    Fungal Infections Market Forecast by Drugs Indication (2018-2023)

10.4.1.      Global Fungal Infections Sales Forecast by Drugs Indication (2018-2023)

10.4.2.      Global Fungal Infections Sales Market Share Forecast by Drugs Indication (2018-2023)

*You can glance through the list of Tables and Figures when you view the sample copy of Fungal Infections Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*